Health And Medicine

Evotec, a drug company headquartered in Hamburg, Germany, has begun a phase 1 clinical trial of a monoclonal antibody against the chikungunya virus that was identified at Vanderbilt University Medical Center. Read More

VUSN Professor Dr. April Kapu, DNP, APRN, ACNP-BC, FAANP, FAAN, was recently interviewed by the Clinical Advisor per the controversy over USDA-HHS Dietary Guidelines. Dr. Kapu commented: “Obesity and detrimental effects of alcohol have tremendous negative consequences on health. I would encourage the USDA-HHS to continue study into the effects of sugar and alcohol consumption and evidence-based... Read More

A new partnership between Vanderbilt University’s Warren Center for Neuroscience Drug Discovery and clinical stage biopharmaceutical company Soleno Therapeutics will further research into new clinical treatments for multiple obesity syndromes. Read More

In Tampa, Florida, in the early 1980s, young men were coming home to their parents to die. As a registered nurse, Julie Barroso cared for many of these AIDS patients in their final days. Read More

Vanderbilt biochemist Yi Ren is part of a team that has identified a new behavior of a SARS-CoV-2 protein and discovered that interfering with its function can block virus replication in host cells. This opens up the potential for new therapeutic targets for COVID-19. Read More

Assistant Professor of Chemistry Steven D. Townsend, PhD’10, has been awarded a 2021 Sloan Research Fellowship, one of the highest honors for young scientists who have the potential to revolutionize their fields of study. Read More

Vanderbilt first-year students recently met with Buddy Creech, director of the Vanderbilt Vaccine Research Program and associate professor of pediatrics, for a special virtual chat to answer some of their COVID-19 vaccine questions. Read More

Bruce Carter, professor of biochemistry and an associate director of the Vanderbilt Brain Institute, has been appointed to the scientific advisory board of the CMT Research Foundation, which shapes research directions and therapeutic development of Charcot-Marie-Tooth disease. Read More

Biomedical researchers across Vanderbilt University will convene to discuss the history and impact of Black biomedical scientists on Monday, Feb. 15, at noon CT. Read More

A new method speeds the analysis of factors that control gene expression from days to minutes, allowing researchers to uncover new targets for cancer treatment. Read More

Researchers will combine expertise in developmental cell biology and tissue engineering/microfluidics to develop highly complex organoids, with the goal of understanding currently incurable neurological disorders.  Read More

Vanderbilt University has joined the Leap Health Breakthrough Network, a global group of leading academic and research institutions committed to solving the world’s most serious health challenges. Read More

For the second time, cancer researchers at Vanderbilt have discovered a protein that—when genetically manipulated to impede it from interacting with a gene responsible for cancer genesis—effectively melts tumors in days. Read More

Molecule 147 neutralizes 95 percent of Dengue and Zika viruses, a promising direction for host-directed treatments and combination therapy. Read More

The latest Vanderbilt Child Health Poll finds that many Tennessee parents are worried about the mental health of their children during the COVID-19 pandemic, and more than 80 percent of parents had concerns about their children attending school remotely. Read More

Researchers at Vanderbilt University Medical Center and colleagues have identified genetic factors that increase the risk for developing pneumonia and its severe, life-threatening consequences. Read More

Thanks to major funding from the National Institutes of Health (NIH), researchers at Vanderbilt University Medical Center have made major inroads in understanding how high-density lipoprotein (HDL), commonly known as good cholesterol, in some cases may... Read More

William Tansey and colleagues identified proteins that interact with the cancer drug target WDR5 and are important for cancer cell growth. Read More

Alexander Bick, MD, PhD, assistant professor of Medicine in the Division of Genetic Medicine at Vanderbilt University Medical Center, has been selected as the first VUMC Discovery Scholar in Health and Medicine. Read More

Discovering the mechanism behind cell behavior that is a hallmark of type 2 diabetes, Vanderbilt researchers move closer to treatments for the disease, which affects 34 million Americans. Read More